76. Pituitary gonadotropin secretion hyperthyroidism Clinical trials / Disease details

Clinical trials : 28 / Drugs : 46 - (DrugBank : 14) / Drug target genes : 6 - Drug target pathways : 19

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02811471 (ClinicalTrials.gov)	June 2016	21/6/2016	Pharmacokinetic Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty	An Open-label, Single Arm, Multicenter Study on the Efficacy, Safety, and Pharmacokinetics of Leuprolide Acetate 45 mg for Injectable Suspension Controlled Release in Subjects With Central (Gonadotropin-Dependent) Precocious Puberty—Part A and B	Central Precocious Puberty	Drug: Leuprolide	Nemours Children's Clinic	Tolmar Inc.	Recruiting	2 Years	9 Years	Both	5	Phase 3	United States
2	NCT02452931 (ClinicalTrials.gov)	August 31, 2015	5/5/2015	Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty	An Open-label, Single Arm, Multicenter Study on the Efficacy, Safety, and Pharmacokinetics of Leuprolide Acetate 45 mg for Injectable Suspension Controlled Release in Subjects With Central (Gonadotropin-Dependent) Precocious Puberty	Precocious Puberty, Central	Drug: Leuprolide Acetate 45 mg	Tolmar Inc.	NULL	Completed	2 Years	9 Years	All	64	Phase 3	United States;Argentina;Canada;Chile;Mexico;New Zealand